Sebaran Data Pasien Rawat Inap Covid-19 Dengan Komplikasi Penyakit Neurologis Diruang Isolasi Kemuning Dalam Periode Juli 2020-Juli 2021 Di RSU Darmayu Ponorogo

Riga Abida Rosyid; Mutia Sinta

doi:10.61722/jinu.v2i2.3961

Authors

Riga Abida Rosyid Rumah Sakit Umum Darmayu Ponorogo
Mutia Sinta Rumah Sakit Umum Darmayu Ponorogo

DOI:

https://doi.org/10.61722/jinu.v2i2.3961

Keywords:

Covid-19 Inpatient Patient Data, Complications of Neurological Disease

Abstract

Several studies have reported evidence that SARSCoV-2 not only attacks the respiratory system but can also attack other organs including the neurological system. Initial data from the Darmayu Ponorogo General Hospital in the Kemuning Isolation Room for the period July 2020 to July 2021 found Covid-19 patients with complications of neurological diseases such as infarct stroke, bleeding stroke, vertigo and epilepsy. Therefore, based on the description above, the author is interested in conducting research on the distribution of data on Covid-19 inpatients with complications of neurological disease in the yellow isolation room in the period July 2020-July 2021 at Darmayu Ponorogo General Hospital. This study uses an observational description of the design using secondary data. This study only wanted to see the distribution of data on Covid-19 inpatients with complications of neurological diseases. The population and sample in this study were all Covid-19 inpatients with complications of neurological disease in the Kemuning Isolation Room in the period July 2020-July 2021 at Darmayu Ponorogo General Hospital as many as 53 respondents. The data analysis method used in this study is univariate analysis, this is done with the aim of seeing a picture of the frequency distribution of Tables and Graphs regarding the distribution of data on Covid-19 inpatients with complications of neurological disease in the Kemuning Isolation Room in the period July 2020-July 2021 in RSU Darmayu Ponorogo. And from the results of the analysis, it can be seen that most of the Covid-19 inpatients in the Isolation Room of Darmayu Ponorogo General Hospital experienced complications of neurological disease in the form of infarction stroke, namely as many as 27 (50.9%) people, as many as 15 (28.3%) people experiencing complications. neurological disease in the form of bleeding stroke, as many as 10 (18.9%) people experienced complications of neurological disease in the form of vertigo and as many as 1 (1.9%) people experienced complications of neurological disease in the form of epilepsy

References

Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., et.al. 2020. “Clinical Characteristics of 113 Deceased Patients with Coronavirus Disease 2019: Retrospective Study.” The BMJ 368: 1–14.

Ellul, M.A., Benjamin, L., Singh, B., Lant, S., Michael, B.D., et.al. 2020. “Neurological Associations of COVID-19.” Lancet Neurol 19: 767–83.

Di Gennaro, F., Pizzol, D., Marotta, C., Antunes, M., Racalbuto, V., et.al. 2020. “Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review.” International journal of environmental research and public health 17(8): 2690.

Guan, W., Ni, Z., Hu, Y., Liang, W., Ou, C., et.al. 2020. “Clinical Characteristics of Coronavirus Disease 2019 in China.” New England Journal of Medicine 382(18): 1708–20.

Handayani, D., Hadi, D.R., Isbaniah, F., Burhan, E. and Agustin, H. 2020. “Corona Virus Disease 2019.” Jurnal Respirologi Indonesia 40(2): 119–29.

Hess et al. 2020. “COVID-19-Related Stroke.” Translational Stroke Research Augusta University.

Kemenkes. Kementrian Kesehatan Republik Indonesia. 2020. “Pedoman Pencegahan Dan Pengendalian Coronavirus Disease (COVID-19).”

Mahalakshmi, A.M., Ray, B., Tuladhar, S., Bhat, A., Paneyala, S., et.al. 2021. “Does COVID-19 Contribute to Development of Neurological Disease?” Immun. Inflamm. Dis. 9: 48–58.

Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., et.al.. 2020. “Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China.” JAMA Neurology.

Nepal, G., Rehrig, J.H., Shrestha, G.S., Shing, Y.K., Yadav, J.K., et.al. 2020. “Neurological Manifestations of COVID-19: A Systematic Review.” Crit. Care 24(421).

Sierra-Hidalgo F, Muñoz-Rivas N, Torres Rubio P, Chao K, Villanova Martínez M, et al. 2020. “Large Artery Ischemic Stroke in Severe COVID-19.” J Neurol.

Spence JD., de Freitas GR., Pettigrew LC., Ay H., Liebeskind DS., et al. 2020. “Mechanisms of Stroke in COVID-19.” Cerebrovasc Dis 20: 1–8.

Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., et.al. 2020. “ISTH Interim Guidance on Recognition and Management of Coagulopathy in COVID-19.” J. Thromb. Haemost. 18: 1023–26.

Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., Et.al. 2020. “Single-Cell RNA Expression Profiling of ACE2, the Putative Receptor of Wuhan 2019-NCov.” BioRxiv, 01(26): 919985.

.